How to suppress lactation 8 months post-weaning from breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

To stop breast milk production that's continuing 8 months after ceasing breastfeeding, the most effective approach is to use a medication like bromocriptine, which has been shown to suppress lactation, although its primary use is in the treatment of conditions like hyperprolactinemia and acromegaly 1. However, considering the context of the provided evidence, which primarily focuses on heart failure management during and after pregnancy, there isn't a direct recommendation for stopping breast milk supply. Given the information available and prioritizing the patient's health and well-being, it's crucial to consider the potential effects of any intervention on both morbidity and mortality, as well as quality of life. In the context of real-life clinical medicine and based on general medical knowledge, techniques such as complete breast emptying followed by no further stimulation, wearing a supportive bra, applying cold compresses, and taking over-the-counter pain relievers like ibuprofen can be recommended as initial steps to reduce milk production. Additionally, avoiding nipple stimulation, breast pumping, or hot showers directed at the breasts is advisable as these can stimulate milk production. Certain herbs like sage tea or medications such as pseudoephedrine may also be considered under medical supervision due to their potential to reduce milk supply. It's essential to consult a healthcare provider if milk production persists, as this could indicate an underlying hormonal issue. The use of bromocriptine or any other medication should be approached with caution and under medical guidance, considering the potential benefits and risks, especially in the context of heart health and other underlying conditions 1. Key considerations include:

  • Avoiding stimulation of the breasts
  • Using cold compresses and supportive clothing
  • Considering herbal remedies or over-the-counter medications under medical supervision
  • Consulting a healthcare provider for persistent lactation or underlying hormonal issues.

From the FDA Drug Label

The prolactin-lowering action of cabergoline suggests that it will interfere with lactation. Due to this interference with lactation, cabergoline should not be given to women postpartum who are breastfeeding or who are planning to breastfeed Use of cabergoline for the inhibition or suppression of physiologic lactation is not recommended (see PRECAUTIONS section).

Stopping breast milk supply can be achieved with cabergoline, as it has a prolactin-lowering action that interferes with lactation. However, its use for this purpose is not recommended.

  • The decision to use cabergoline for stopping breast milk supply should be made with caution, considering the potential risks and benefits.
  • It is essential to consult a healthcare provider before using cabergoline for this purpose, especially if the woman is still experiencing lactation 8 months after not breastfeeding 2.

From the Research

Stopping Breast Milk Supply

To stop breast milk supply 8 months after not breastfeeding, it is essential to understand the underlying causes of persistent lactation.

  • Hyperprolactinemia, a condition characterized by elevated prolactin levels, can lead to galactorrhea (spontaneous milk production) and other symptoms 3, 4, 5, 6, 7.
  • Dopamine agonists, such as cabergoline and bromocriptine, are commonly used to treat hyperprolactinemia by suppressing prolactin secretion 3, 4, 5, 6, 7.

Treatment Options

  • Cabergoline has been shown to be effective in reducing prolactin levels and normalizing menstrual function in women with hyperprolactinemia 3, 5, 6, 7.
  • Bromocriptine is also effective in reducing prolactin levels, but it may have more side effects compared to cabergoline 3, 4, 5, 6.
  • Quinagolide is another dopamine agonist that has been used to treat hyperprolactinemia, but its efficacy and safety profile are less well-studied compared to cabergoline and bromocriptine 6.

Considerations

  • The choice of treatment should be individualized based on the patient's specific needs and medical history 3, 4, 5, 6, 7.
  • Regular monitoring of prolactin levels and other health parameters is essential to ensure the effectiveness and safety of treatment 3, 4, 5, 6, 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

IMPULSE CONTROL DISORDERS IN PATIENTS WITH HYPERPROLACTINEMIA ON DOPAMINE AGONIST THERAPY - HOW CONCERNED SHOULD WE BE?

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.